We are live on ! Find out more
DWA

Douglass Winthrop Advisors Portfolio holdings

AUM $5.46B
1-Year Est. Return 11.49%
This Fund
S&P 500
This Quarter Est. Return
+9.9%
1 Year Est. Return
+11.49%
3 Year Est. Return
+66.59%
5 Year Est. Return
+87.07%
10 Year Est. Return
+344%
AUM
$4.46B
AUM Growth
+$379M
Cap. Flow
-$2.75M
Cap. Flow %
-0.06%
Top 10 Hldgs %
41.22%
Holding
285
New
10
Increased
68
Reduced
90
Closed
12

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$67.5M
2
SPOT icon
Spotify
SPOT
+$55.4M
3
BDX icon
Becton Dickinson
BDX
+$22.7M
4
ECL icon
Ecolab
ECL
+$7.65M
5
AAPL icon
Apple
AAPL
+$4.53M

Sector Composition

Rank Sector Weight
1 Financials 23.65%
2 Technology 19.02%
3 Consumer Discretionary 13.03%
4 Communication Services 10.02%
5 Industrials 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VLO icon
126
Valero Energy
VLO
$90.1B
$1.01M 0.02%
13,400
BAC icon
127
Bank of America
BAC
$435B
$1M 0.02%
22,557
+58
+0.3% +$2.64K
QCOM icon
128
Qualcomm
QCOM
$155B
$995K 0.02%
5,443
+190
+4% +$30.4K
LH icon
129
Labcorp
LH
$25B
$987K 0.02%
3,655
-233
-6% -$57.7K
UL icon
130
Unilever
UL
$137B
$961K 0.02%
15,874
-391
-2% -$23.2K
AME icon
131
Ametek
AME
$55.4B
$960K 0.02%
6,528
-200
-3% -$27.4K
DD icon
132
DuPont de Nemours
DD
$18.5B
$954K 0.02%
9,413
+274
+3% +$26.1K
LOW icon
133
Lowe's Companies
LOW
$117B
$945K 0.02%
3,655
-200
-5% -$47.5K
NEM icon
134
Newmont
NEM
$98.7B
$927K 0.02%
14,950
+2,000
+15% +$113K
CVS icon
135
CVS Health
CVS
$133B
$903K 0.02%
8,750
-989
-10% -$91.4K
SYK icon
136
Stryker
SYK
$125B
$899K 0.02%
3,363
GILD icon
137
Gilead Sciences
GILD
$162B
$889K 0.02%
12,250
+3,250
+36% +$224K
EMR icon
138
Emerson Electric
EMR
$83.9B
$886K 0.02%
9,530
ADM icon
139
Archer Daniels Midland
ADM
$38.2B
$875K 0.02%
12,952
EL icon
140
Estee Lauder
EL
$30.4B
$861K 0.02%
2,326
+24
+1% +$8.15K
TRV icon
141
Travelers Companies
TRV
$78.1B
$857K 0.02%
5,480
WFC icon
142
Wells Fargo
WFC
$261B
$856K 0.02%
17,839
APD icon
143
Air Products & Chemicals
APD
$65.7B
$852K 0.02%
2,800
EQIX icon
144
Equinix
EQIX
$101B
$834K 0.02%
986
-4,228
-81% -$3.39M
NVS icon
145
Novartis
NVS
$297B
$832K 0.02%
9,516
-4,792
-33% -$398K
CL icon
146
Colgate-Palmolive
CL
$73.1B
$830K 0.02%
9,728
-2,681
-22% -$209K
ISRG icon
147
Intuitive Surgical
ISRG
$127B
$813K 0.02%
2,262
+24
+1% +$8.26K
SJM icon
148
J.M. Smucker
SJM
$12.7B
$808K 0.02%
5,950
CDW icon
149
CDW
CDW
$18.9B
$800K 0.02%
3,906
MDT icon
150
Medtronic
MDT
$109B
$799K 0.02%
7,723
+39
+0.5% +$4.52K

Similar funds

Douglass Winthrop Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Douglass Winthrop Advisors held 285 positions worth $4.46B, up 9.3% from $4.08B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Douglass Winthrop Advisors's Q4 2021 filing shows 10 new, 68 increased, 90 reduced and 12 closed positions. Its largest new stake was ASML: 5,178 shares worth $4.12M. The largest sale was Merck, an estimated $67.5M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Douglass Winthrop Advisors's largest Q4 2021 buy was ASML: 5,178 shares worth $4.12M.
  • Douglass Winthrop Advisors added most to Autodesk in Q4 2021, an estimated $88.6M increase.
  • Douglass Winthrop Advisors's biggest Q4 2021 reduction was Merck, cutting an estimated $67.5M.
  • Douglass Winthrop Advisors fully exited ChampionX in Q4 2021, selling an estimated $1.02M.
  • Douglass Winthrop Advisors's ten largest holdings make up 41% of its $4.46B portfolio in Q4 2021.
  • Douglass Winthrop Advisors opened 10 new positions and closed 12 in Q4 2021.
  • Douglass Winthrop Advisors's portfolio value rose 9.3% quarter-over-quarter to $4.46B.

Based on Douglass Winthrop Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.